EI.Ventures is a subsidiary of Orthogonal Thinker that is currently raising $50 million. Though scant on details, the company is developing Psilly (whole-plant botanical psilocybin-based formulation) and has (presumably) launched a consumer non-psychedelic mushroom brand ‘Mana’.
Emotional Intelligence Ventures
The company’s aim is to deliver “governmental approved therapeutic treatments” to address the existing global mental healthcare crisis and also contribute to research in academic understanding of psychoactive compounds.
Up to February 2022, it has raised more than $20 million of the (maximum of) $50 million fundraising to IPO. There have also been talks of merging with Mycotopia, a subsidiary of Ehave.
Activities
B2C
Retail
Compounds of Interest
Psilocybin
Topics of Interest
Depression
Healthy Subjects
Explore more company info with a Tree membership
📰 Weekly newsletter about the business of psychedelics
📈 Extended company information (analyst view, fundraising, revenue numbers)
🪄 Priority company page updates
Company News
Emotional Intelligence Ventures and Mycotopia enter a Definitive Agreement on $382M merger transaction (GlobeNewswire, 19 May 2022)Ehave Plans Stock Distribution; Mycotopia Therapies Plans To Merge With Ei. Ventures (Yahoo Finance, 08 December 2021)
Mycotopia and Ei.Ventures announced the signing of an LOI to explore a merger and the formation of PSLY.COM, a $360 Million transaction, and will apply to list shares on NASDAQ; Ehave plans to spin out 30%.
Emotional Intelligence Ventures Announces Their Qualification of a Regulation A+ Public Stock Offering (Business Wire, 01 March 2021)